Florida signs $245 million in contracts for 'Alligator Alcatraz.' Here's a look by the numbers
The amount — to be fronted by Florida taxpayers — is in line with the $450 million a year officials have estimated the facility will cost.
It's also a reminder of the public funding that DeSantis' Republican administration is spending to help carry out President Donald Trump 's mass deportation agenda.
Human rights advocates, faith leaders and environmentalists have condemned the detention center. So has Mark Morgan, a former acting director of Immigration and Customs Enforcement during Trump's first term. Morgan wrote an opinion piece published by Fox News criticizing the facility as 'built for headlines' and 'ripe for failure, mismanagement and corruption.'
Here's a look by the numbers.
More than $245 million allocated so far
A state database of government contracts shows that since Florida officials announced plans for the facility on June 19, the Executive Office of the Governor has awarded at least two dozen contracts totaling more than $245 million in taxpayer funds to build and manage the facility. It rose in a matter of days from a county-owned airstrip surrounded by swampland about 45 miles (72 kilometers) west of downtown Miami.
All the contracts were awarded under an executive order declaring an illegal immigration emergency the governor first enacted in 2023 and which he has renewed since then. The order grants the state sweeping authority to suspend 'any statute, rule or order' seen as slowing the response to the emergency, including requirements to competitively bid public contracts.
State officials say at least some of the cost will be covered by the Federal Emergency Management Agency, which is best known for responding to hurricanes and other natural disasters. But in court documents filed earlier this month, attorneys for the Department of Homeland Security stated that the federal government had yet to reimburse Florida for any of the costs. The department made clear that 'Florida is constructing and operating the facility using state funds on state lands under state emergency authority.'
The largest contract totals $78.5 million
The single largest state contract related to the facility is a $78.5 million deal with Critical Response Strategies, a Jacksonville-based consulting firm. The responsibilities covered include hiring a warden, camp managers, corrections officers and IT workers.
Other major contractor include Longview Solutions Group, which is being paid $25.6 million for site preparation, civil engineering, road construction and fence installation. Doodie Calls, a St. Petersburg-based supplier of portable toilets and shower trailers, was awarded a $22 million contract.
The firm Gothams landed a $21.1 million contract to provide IT services, access badges and wristbands for detainees, while SLSCO LTD and Garner Environmental Services were both awarded $19.7 million deals to build out the site and handle ongoing maintenance.
Corrections officers to be paid up to $11,600 a month
One of the contracts shared with The Associated Press shows Critical Response Strategies was set hire a warden for the temporary facility at $125 an hour and potentially spend more than $400,000 in overtime pay. It's not clear how long staffers can expect to work at the facility.
Corrections officers at the facility can expect to earn up to $11,600 a month, plus overtime, according to a job posting for the company on LinkedIn. The starting pay for Florida's rank-and-file corrections officers is $22 an hour or about $3,800 a month at the state's brick-and-mortar prisons, which have been so persistently understaffed that DeSantis deployed members of the Florida National Guard to work at them for more than two years.
Zero publicly available contract documents
As journalists and watchdogs have raised questions about the contracts and companies behind them, documents detailing deliverables and line-item spending have disappeared from the state's website. They've been replaced with one-page invoices that show little more than the names of the companies, how much they're charging, the dates on which each deal was signed and an address for where to send the bill.
Some multimillion dollar contracts were awarded to political donors who have given to campaigns supporting DeSantis and other Republicans.
The governor's office directed questions about the contracts to the Florida Division of Emergency Management, the state agency in charge of building the detention center. Spokesperson Stephanie Hartman said the contracts were removed because they included 'proprietary information that shouldn't have been uploaded.'
The department did not answer questions about whether the full contracts would be released.
___
Kate Payne is a corps member for The Associated Press/Report for America Statehouse News Initiative. Report for America is a nonprofit national service program that places journalists in local newsrooms to report on undercovered issues.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
a few seconds ago
- Bloomberg
Hakeem Jeffries to Visit Texas as Trump Pushes Redrawing Congressional Maps
Hakeem Jeffries, the Democratic leader in the US House of Representatives, will meet with Texas Democrats in Austin on Wednesday, according to people familiar with the matter, as a national battle intensifies over President Donald Trump's drive to redraw the state's congressional maps. Trump has said that revamping Texas congressional districts would add as many as five seats for the Republicans, giving the party a leg up as it seeks to defend its narrow House majority in midterm elections next year. Texas state lawmakers have been holding hearings on the controversial effort, but new proposed maps have yet to be released.
Newsweek
a few seconds ago
- Newsweek
Trump's EU Deal Could Cost Pharma Industry $19 Billion, Analyst Warns
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The trade deal struck between the European Union and the United States over the weekend could cost the pharmaceutical industry billions, thanks to the 15 percent tariff rate applied to most goods under the terms of the agreement. Though the EU is set to invest hundreds of billions of dollars into the U.S. through energy purchases and other investments, pharmaceutical companies could incur additional expenses totaling $19 billion, according to Bernstein analyst Courtney Breen, cited by Reuters. Breen added that firms could mitigate some of these costs through inventory stockpiling and other strategies. Newsweek reached out to the Commerce Department and European Commission via email for comment. Why It Matters Pharmaceuticals were the fifth most imported product to the U.S. in 2024, according to the Observatory of Economic Complexity think tank, and EU member nations accounted for the lion's share of these. While certain aspects of the preliminary trade deal are yet to be finalized and remain subject to approval by European leaders, 15 percent tariffs could prove a significant challenge for companies reliant on imported European pharmaceuticals, while resulting in higher drug prices for U.S. consumers. This is in addition to the impact on European pharma firms, which are already bracing for the results of the ongoing Commerce Department investigation into whether imported pharmaceuticals constitute a threat to U.S. national security that justifies even more levies. What To Know The preliminary agreement between the U.S. and EU was unveiled during a meeting between President Donald Trump and European Commission President Ursula von der Leyen in Scotland on Sunday. The pair contradicted each other on the question of pharmaceuticals—the former saying these were exempt and the latter saying the opposite, resulting in differing reports on whether European drugs would be subject to the agreed 15-percent tariff rate. However, officials from both sides later confirmed the 15 percent rate on pharmaceutical imports, according to reports from Bloomberg and Reuters. In a subsequent press conference, von der Leyen said that the only exception for pharma products would be for "certain generics," without specifying what these would be. Main: President Donald Trump at a meeting with European Commission President Ursula von der Leyen in Turnberry, Scotland, on July 27, 2025. Inset: Stock image of medications. Main: President Donald Trump at a meeting with European Commission President Ursula von der Leyen in Turnberry, Scotland, on July 27, 2025. Inset: Stock image of medications. Frank May / Andrew Harnik/picture-alliance/dpa/AP Images / Getty Images Pharmaceutical firms are also bracing for the outcome of an ongoing investigation by the Commerce Department into the national security implications of America's medicine imports. This probe was launched in April by Commerce Secretary Howard Lutnick under Section 232 of the 1962 Trade Expansion Act. Should it conclude that pharmaceutical imports threaten U.S. security, this could result in import restrictions or a higher tariff regardless of Sunday's agreement with the EU. However, Reuters cited Wall Street analysts as saying that the investigation will not result in additional sectoral duties for the EU, though it noted that this aspect of the agreement remains unclear. According to Euronews, citing EU sources familiar with the matter, pharmaceuticals were technically excluded from Sunday's agreement, and any decision by Trump to impose or lessen tariffs on them would have to wait until after the investigation concludes. What People Are Saying European Commission Ursula von der Leyen, at a press conference: "It's agreed that we have 15 percent [tariffs] for pharmaceuticals. Whatever the decision later on is, of the president of the U.S., how to deal with pharmaceuticals in general globally, that's on a different sheet of paper." She said earlier that the 15 percent tariff rate is "a clear ceiling. So no stacking. All-inclusive." Kimberley Clausing, an economist and professor of Tax Law and Policy at UCLA School of Law, told Newsweek: "The United States is levying large new tariffs, so the United States consumers will suffer from larger tax increases than their European counterparts. But some European producers will also be harmed by reduced U.S. market access." "On net, the Europeans have the advantage, since they at least can maintain free and open trade with other partners while the United States is busy destroying the gains from trade with all of our trading partners." What Happens Next It is unclear when the results of the ongoing investigation into pharmaceutical imports might be made public.
Epoch Times
a few seconds ago
- Epoch Times
Russian Officials Respond to Trump's Ukraine Deadline Change
Top Russian officials on Tuesday responded to President Donald Trump's new deadline for Russia to make progress toward a cease-fire with Ukraine. On Monday, Trump told reporters in Scotland that he is 'very disappointed' in Russian President Vladimir Putin for continuing the conflict, saying he would shorten a 50-day negotiating window to 10 days.
